Qube Research & Technologies Ltd - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$16,670
-57.8%
8,212
-52.2%
0.00%
Q2 2023$39,509
-40.8%
17,178
-22.0%
0.00%
Q1 2023$66,733
+42.0%
22,024
+42.3%
0.00%
-100.0%
Q2 2021$47,000
-88.3%
15,474
-87.2%
0.00%
-83.3%
Q1 2021$401,000
-70.6%
120,529
-68.6%
0.01%
-68.4%
Q4 2020$1,364,000
+957.4%
384,297
+835.6%
0.02%
+850.0%
Q3 2020$129,000
+20.6%
41,074
-30.3%
0.00%0.0%
Q2 2020$107,000
+143.2%
58,913
+34.1%
0.00%0.0%
Q1 2020$44,000
-90.5%
43,919
-73.6%
0.00%
-85.7%
Q4 2019$462,000166,1380.01%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders